Omnicell (NASDAQ:OMCL) Upgraded to “Overweight” at Wells Fargo & Company
Wells Fargo & Company upgraded shares of Omnicell (NASDAQ:OMCL – Free Report) from an equal weight rating to an overweight rating in a research report sent to investors on Wednesday morning, MarketBeat.com reports. The brokerage currently has $35.00 price target on the stock, up from their prior price target of $31.00. Several other research analysts […]
